Skip to main navigation Skip to search Skip to main content

Rapid development of an efficacious swine vaccine for novel H1N1

  • Ryan Vander Veen
  • , Kurt Kamrud
  • , Mark Mogler
  • , Alan T. Loynachan
  • , Jerry McVicker
  • , Peter Berglund
  • , Gary Owens
  • , Sarah Timberlake
  • , Whitney Lewis
  • , Jonathan Smith
  • , D. L.Hank Harris

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Recombinant hemagglutinin (HA) from a novel H1N1 influenza strain was produced using an alphavirus replicon expression system. The recombinant HA vaccine was produced more rapidly than traditional vaccines, and was evaluated as a swine vaccine candidate at different doses in a challenge model utilizing the homologous influenza A/California/04/2009 (H1N1) strain. Vaccinated animals showed significantly higher specific antibody response, reduced lung lesions and viral shedding, and higher average daily gain when compared to non-vaccinated control animals. These data demonstrate that the swine vaccine candidate was efficacious at all of the evaluated doses.

Original languageEnglish
Article numberecurrents.RRN1123
JournalPLoS Currents
Issue numberOCT
DOIs
StatePublished - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Fingerprint

Dive into the research topics of 'Rapid development of an efficacious swine vaccine for novel H1N1'. Together they form a unique fingerprint.

Cite this